Garry A. Neil - Insider Trading & Ownership

Location
555 California Street, Suite 365, San Francisco, CA
Summary
The estimated net worth of Garry A. Neil is at least $2.09M dollars as of June 9, 2025. Garry A. Neil is the Chief Executive Officer of Avalo Therapeutics, Inc. and owns shares of Avalo Therapeutics, Inc. (AVTX) stock worth about $2.09M.
Signature
/s/ Sam Martin, attorney-in-fact for Garry A. Neil, M.D.
All Insider Reports
All Insider Reports

Ownership of Garry A. Neil

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AVTX Avalo Therapeutics, Inc. Chief Executive Officer $2.09M Mar 28, 2025
ARNA ARENA PHARMACEUTICALS INC Director Mar 11, 2022
CLDX Celldex Therapeutics, Inc. Director Jun 5, 2025
ZURA Zura Bio Ltd Director May 18, 2023

Insider Transactions Reported by Garry A. Neil:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.